Organized crime and terrorist organisations are often at the forefront of technological innovation in planning, executing and concealing their criminal activities and the revenues stemming from them. Law Enforcement Agencies (LEAs) are often lagging behind when tackling criminal activities supported by advanced technologies.
Groupement d’intérêt public « recherche » créé le 12 novembre 2009, le Conseil supérieur de la formation et de la recherche stratégiques (CSFRS) comprend vingt-deux membres, répartis en trois collèges : représentants de l’État, organismes ou instituts de formation et de recherche, entreprises ou organismes du secteur privé.
NUSANTARA est le Partenariat Hubert Curien franco-indonésien. Il est mis en œuvre en France par le Ministère de l’Europe et des Affaires étrangères (MEAE) et le Ministère de l'Enseignement Supérieur et de la Recherche (MESR), et dans le pays partenaire par le Ministère de l’Education, de la Culture, de la Recherche et de la Technologie (KEMDIKBUDRISTEK).
Les appels à candidatures de ce programme sont lancés sur un rythme annuel.
Date limite de dépôt des dossiers de candidature : 12/09/2023
The Korean Studies Grant Program provides academic support for scholars of Korean Studies affiliated with overseas universities or research institutes with the aim of revitalizing and improving Korean Studies programs overseas. In the latter half of each year, candidates are selected through open competitions and provided with support for their academic activities related to Korean studies in five categories. All Korean Studies scholars from overseas universities and research institutes are welcome to apply.
Principal appel de l’Agence nationale de la recherche (ANR), l’Appel à projets générique 2025 (AAPG 2025) s’adresse à toutes les communautés scientifiques et à tous les acteurs publics ou privés impliqués dans la recherche française. Il doit permettre aux chercheurs et chercheuses des différents domaines scientifiques, d’accéder, en complément des financements récurrents qui leur sont alloués, à des co-financements sur un grand nombre de thématiques de recherche, finalisées ou non.
Etape I
In most European countries, absences from work and early retirement due to mental illness have increased in recent years. Mental health conditions such as depression, anxiety and stress represent substantial financial costs for employers and employees, as well as a significant loss for society at large. An EU-level estimate of the overall costs, direct health costs and lost productivity is more than 450 billion EUR per year.
Each year, an estimated 213 million women become pregnant and 140 million newborn babies are delivered. However, many of the women and infants receive no appropriate care or care that is below evidence-based standards; others suffer from over-medicalisation. Access to quality care, during and after pregnancy, is essential to ensure good maternal health and the favourable early development of the child.
Citizens in a rapidly ageing European population are at greater risk of cognitive impairment, frailty and multiple chronic health conditions with considerable negative consequences for their independence, quality of life and for the sustainability of health and care systems. The challenge is to foster large-scale deployment of integrated digital solutions which will bring improved quality of life to citizens while demonstrating significant efficiency gains in health and care delivery across Europe.
Despite the general acknowledgement by the scientific community that 'Genetics load the gun but environment pulls the trigger' when it comes to the causation of major non-communicable diseases (NCDs), there is persistent uncertainty as to the global burden of disease attributable to environmental (including life-style and climatic) factors, including healthcare costs and negative economic impact. Deciphering the human exposome is a novel way of addressing the challenge to improve health and reduce the overall burden of disease.
Personalised medicine (PM) has the potential to respond to, among others, the increasing burden of co-morbidities and thus enhance the sustainability of healthcare systems. With the increasing number of scientific approaches available, it is crucial to demonstrate the benefit of large scale deployment of personalised medicine to citizens and healthcare systems. This was also one of the conclusions of the Personalised Medicine Conference 2016.